• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于甲状腺结节活检结果不明确的患者,甲状腺切除术前是否需要检测血清降钙素?

Is there a place for measuring serum calcitonin prior to thyroidectomy in patients with a non-diagnostic thyroid nodule biopsy?

机构信息

Serviço de Endocrinologia e Metabologia, Hospital de Clínicas, Universidade Federal do Paraná (SEMPR), Curitiba, PR, Brasil,

Universidade Estadual do Oeste do Paraná (Unioeste), Cascavel, PR, Brasil.

出版信息

Arch Endocrinol Metab. 2021 Nov 1;65(1):40-48. doi: 10.20945/2359-3997000000320. Epub 2021 Jan 14.

DOI:10.20945/2359-3997000000320
PMID:33444493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10528694/
Abstract

OBJECTIVE

To verify the cytopathological Bethesda System classification of thyroid nodule fine-needle aspiration biopsy (FNAB) in MTC patients and to assess the role of preoperative serum calcitonin (CT) levels in the investigation of this neoplasm in medullary thyroid cancer (MTC) patients under observation at the Uopeccan ().

METHODS

This is a cross-sectional review of medical records of patients monitored at the thyroid cancer outpatient clinic of Uopeccan. Clinical and demographic data, laboratory tests, ultrasound images, and cytopathological findings of MTC patients were evaluated.

RESULTS

Among the 360 patients with thyroid cancer monitored in the outpatient clinic, 5.2% (n: 19/360) had MTC. The hereditary form was more prevalent (63.2%), and there was no sex preference. The most common ultrasound findings were hypoechogenicity, solid appearance and microcalcifications. The FNAB diagnoses showed a sensitivity of 47.1%, and the most common cytopathological report was Bethesda category III. Serum CT levels showed good sensitivity (84.6%) for the diagnosis of MTC, and sensitivity levels were directly associated with the size of the nodule and distant metastases.

CONCLUSION

Bethesda category III was more prevalent in this group of MTC patients. Serum CT levels were more sensitive than cytopathology for diagnosis of this neoplasm and were able to identify all patients who could not be diagnosed by FNAB.

摘要

目的

验证甲状腺结节细针抽吸活检(FNAB)在 MTC 患者中的细胞病理学 Bethesda 系统分类,并评估术前降钙素(CT)水平在观察性髓样甲状腺癌(MTC)患者中的作用。

方法

这是对 Uopeccan 甲状腺癌门诊监测的 MTC 患者的病历进行的一项横断面回顾性研究。评估了 MTC 患者的临床和人口统计学数据、实验室检查、超声图像和细胞病理学结果。

结果

在门诊监测的 360 例甲状腺癌患者中,5.2%(n:19/360)为 MTC。遗传性形式更为常见(63.2%),无性别偏好。最常见的超声表现为低回声、实性外观和微钙化。FNAB 诊断的敏感性为 47.1%,最常见的细胞病理学报告为 Bethesda 类别 III。血清 CT 水平对 MTC 的诊断具有良好的敏感性(84.6%),并且敏感性水平与结节大小和远处转移直接相关。

结论

在该组 MTC 患者中,Bethesda 类别 III 更为常见。与 FNAB 相比,血清 CT 水平对该肿瘤的诊断更为敏感,并且能够识别所有不能通过 FNAB 诊断的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/4f67f0c7259d/2359-4292-aem-65-01-0040-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/7c85733ab4f0/2359-4292-aem-65-01-0040-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/9b149082112e/2359-4292-aem-65-01-0040-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/4f67f0c7259d/2359-4292-aem-65-01-0040-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/7c85733ab4f0/2359-4292-aem-65-01-0040-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/9b149082112e/2359-4292-aem-65-01-0040-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc03/10528694/4f67f0c7259d/2359-4292-aem-65-01-0040-gf03.jpg

相似文献

1
Is there a place for measuring serum calcitonin prior to thyroidectomy in patients with a non-diagnostic thyroid nodule biopsy?对于甲状腺结节活检结果不明确的患者,甲状腺切除术前是否需要检测血清降钙素?
Arch Endocrinol Metab. 2021 Nov 1;65(1):40-48. doi: 10.20945/2359-3997000000320. Epub 2021 Jan 14.
2
Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma.细胞学与降钙素测定在细针抽吸活检洗脱液(FNAB-CT)中的应用对诊断甲状腺髓样微癌的价值。
Endocrine. 2021 Nov;74(2):340-348. doi: 10.1007/s12020-021-02759-1. Epub 2021 May 24.
3
The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.降钙素在甲状腺细针抽吸洗脱液中的检测对髓样甲状腺癌的诊断价值。
Endocr Pract. 2013 Sep-Oct;19(5):769-79. doi: 10.4158/EP12420.OR.
4
Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.原发性和转移性甲状腺髓样癌患者颈部肿块细针穿刺冲洗液中降钙素的测定
J Clin Endocrinol Metab. 2007 Jun;92(6):2115-8. doi: 10.1210/jc.2007-0326. Epub 2007 Apr 3.
5
An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.一位老朋友,新的见解:血清降钙素测量和抽吸针洗脱液显著提高了甲状腺髓样癌的早期和准确检测。
Cancer Cytopathol. 2024 Mar;132(3):161-168. doi: 10.1002/cncy.22779. Epub 2023 Nov 10.
6
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone.细针抽吸和髓样甲状腺癌:仅依靠 FNAB 细胞学检查时,术前评估不足和初始手术的风险。
Endocr Pract. 2013 Nov-Dec;19(6):920-7. doi: 10.4158/EP13143.OR.
7
Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens.通过细针穿刺活检标本中的降钙素测量诊断甲状腺髓样癌
Thyroid. 2007 Jul;17(7):635-8. doi: 10.1089/thy.2006.0338.
8
Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.甲状腺髓样癌的术前诊断:细针穿刺细胞学检查与血清降钙素测定的比较
J Surg Oncol. 2005 Jul 1;91(1):56-60. doi: 10.1002/jso.20269.
9
The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.血清降钙素在甲状腺结节细胞学检查不充分、不确定和可疑时的常规测量价值。
Bosn J Basic Med Sci. 2022 Feb 1;22(1):118-123. doi: 10.17305/bjbms.2021.5756.
10
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.

引用本文的文献

1
Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation.微小RNA在甲状腺癌和乳腺癌进展中的调节作用及其治疗调控的研究进展
Curr Res Pharmacol Drug Discov. 2022 Oct 3;3:100131. doi: 10.1016/j.crphar.2022.100131. eCollection 2022.
2
Suboptimal accuracy of ultrasound and ultrasound-based risk stratification systems in detecting medullary thyroid carcinoma should not be overlooked. Findings from a systematic review with meta-analysis.超声和基于超声的风险分层系统在检测甲状腺髓样癌方面的准确性不够理想,这一点不应被忽视。系统评价和荟萃分析的结果。
Clin Endocrinol (Oxf). 2022 Nov;97(5):532-540. doi: 10.1111/cen.14739. Epub 2022 Apr 22.
3

本文引用的文献

1
Dynamic risk stratification in medullary thyroid carcinoma: Single institution experiences.甲状腺髓样癌的动态风险分层:单机构经验
Medicine (Baltimore). 2018 Jan;97(3):e9686. doi: 10.1097/MD.0000000000009686.
2
Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.髓样甲状腺癌:散发性疾病检测中生存分析及突变特异性免疫组化评估
World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.
3
Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.
The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.
血清降钙素在甲状腺结节细胞学检查不充分、不确定和可疑时的常规测量价值。
Bosn J Basic Med Sci. 2022 Feb 1;22(1):118-123. doi: 10.17305/bjbms.2021.5756.
测定基础血清降钙素用于甲状腺髓样癌的诊断。
Horm Metab Res. 2018 Jan;50(1):23-28. doi: 10.1055/s-0043-122237. Epub 2017 Nov 23.
4
Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.甲状腺髓样癌的细针穿刺细胞学检查:日本单机构经验
Endocr J. 2017 Nov 29;64(11):1099-1104. doi: 10.1507/endocrj.EJ17-0238. Epub 2017 Sep 5.
5
Perioperative Management of Pheochromocytoma.嗜铬细胞瘤的围手术期管理
J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1427-1439. doi: 10.1053/j.jvca.2017.02.023. Epub 2017 Feb 4.
6
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee.美国放射学会甲状腺影像报告和数据系统(TI-RADS):美国放射学会TI-RADS委员会白皮书
J Am Coll Radiol. 2017 May;14(5):587-595. doi: 10.1016/j.jacr.2017.01.046. Epub 2017 Apr 2.
7
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
8
Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.甲状腺髓样癌中细针穿刺活检细胞学检查的检出率:一项荟萃分析。
Clin Endocrinol (Oxf). 2015 Feb;82(2):280-5. doi: 10.1111/cen.12563. Epub 2014 Aug 14.
9
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS): Is there a correct answer?分类为贝塞斯达III类(AUS/FLUS)的甲状腺结节的恶性率:有正确答案吗?
Thyroid. 2014 May;24(5):787-8. doi: 10.1089/thy.2014.0142.
10
Medullary thyroid cancer diagnosis: an appraisal.甲状腺髓样癌的诊断:一项评估。
Head Neck. 2014 Aug;36(8):1216-23. doi: 10.1002/hed.23449. Epub 2014 Mar 4.